Malaysia pacemaker market is anticipated to witness a growth of steady CAGR during the forecast period. The pacemaker market in Malaysia has witnessed a remarkable growth over the past few years, owing to the increasing prevalence of cardiovascular disease and cardiovascular surgeries in Malaysia.
According to the National Health and Morbidity Survey (NHMS) conducted in 2019, the prevalence of CVD in Malaysia was 15.6%, up from 13.7% in 2015.
Also, rising healthcare expenditure is driving the pacemaker market in Malaysia. The Malaysian government has increased its healthcare expenditure in recent years, with a focus on improving healthcare infrastructure and increasing access to medical services. This has led to an increase in the number of hospitals and healthcare facilities in the country, which has further increased the demand for pacemakers, thereby expanding the Malaysia pacemaker market.
Increasing Cases of Arrhythmia and Bradycardia in Malaysia
Arrhythmia and bradycardia are two heart conditions that are becoming increasingly prevalent in Malaysia. Arrhythmia is a condition where the heart beats irregularly or too quickly, while bradycardia is a condition where the heart beats too slowly. Both conditions can lead to serious health complications if left untreated.
According to the World Health Organization (WHO), the percentage of people aged 65 years and older in Malaysia is expected to increase from 5.1% in 2020 to 9.9% in 2050.
Another contributing factor is the lifestyle changes in Malaysia, such as a sedentary lifestyle, poor diet, and increasing stress levels. These factors can increase the risk of developing cardiovascular disease, which, in turn, increases the likelihood of developing arrhythmia or bradycardia.
(according to a 2020 data by WHO, stroke deaths in Malaysia accounted for 12.85% of total deaths)
The increasing incidence of arrhythmia and bradycardia in Malaysia is also putting a strain on the country's healthcare system. The cost of treatment for these conditions can be high, especially for patients who require long-term care. This can be a burden on both the patients and their families.
Preventing arrhythmia and bradycardia involves making lifestyle changes such as adopting a healthy diet, exercising regularly, reducing stress, and quitting smoking. Early detection is also essential, and patients who have a family history of heart disease or experience symptoms such as palpitations, dizziness, or shortness of breath should seek medical attention promptly.
Treatment for arrhythmia and bradycardia in Malaysia typically involves medication, lifestyle changes, and in severe cases, the use of pacemakers or implantable cardioverter-defibrillators (ICDs), thereby fuelling the Malaysia pacemaker market.
Advances in Technology
Pacemakers are small electronic devices that are implanted under the skin of the chest to help regulate an irregular heartbeat. These are life-saving devices for millions of people across the world, and these have been in use for several decades. However, over the years, technological advancements have led to significant improvements in pacemaker technology, making them more effective and efficient than ever before. Some of the technological advancements in pacemakers are
Furthermore, the usage of cardiac resynchronization therapy device pacemaker (CRT-P) devices in Malaysia has increased significantly over the past few years. A CRT-P device is a small electronic device that is implanted under the skin in the chest area. It is similar to a traditional pacemaker but has additional features that help to synchronize the contractions of the heart's ventricles. This improves the heart's pumping ability and helps to reduce symptoms of heart failure such as fatigue, shortness of breath, and swelling in the legs.
Cardiac resynchronization therapy (CRT) is a treatment option for people with heart failure who have a specific type of abnormal heartbeat. This treatment involves the use of a CRT-P to help regulate the heartbeat and improve the patient's quality of life.
Surge in Elderly Population in Malaysia
Malaysia, like many other countries around the world, is experiencing a significant demographic shift with a growing geriatric population. This is due to a combination of factors, including advancements in healthcare, improved living standards, and a decrease in birth rates.
The growing geriatric population in Malaysia has several implications, including
Increased healthcare needsAs individuals age, they are more likely to develop chronic health conditions that require ongoing medical care. This puts a strain on the healthcare system, as there are more patients requiring medical attention.
Increased demand for elderly care servicesAs the geriatric population grows, there is an increased demand for elderly care services, such as assisted living facilities, nursing homes, and home care services.
Economic implicationsAn aging population can have economic implications, such as increased healthcare costs, decreased productivity, and increased dependency ratios.
Market Segmentation
The Malaysia pacemaker market can be segmented by type, application, end user, source, and by region. Based on type, the market can be divided into diagnostic & monitoring devices and surgical devices. Based on application, the market can be segmented into coronary artery disease, cardiac arrhythmia, heart failure, and others. Based on end user, the market can be fragmented into hospitals & clinics, diagnostic centers, and others. Based on source, the market can be split into import and domestic.
Market Players
Medtronic Malaysia Sdn Bhd, Boston Scientific Medical Device (Malaysia) Sdn. Bhd., BIOTRONIK Medical Devices (Malaysia) SDN BHD, Abbott Malaysia Sdn Bhd, and Osypka Medical Asia Pacific Sdn Bhd, are some of the leading players operating in the Malaysia pacemaker market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, Volume in Million Units and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | By Type By Technology By Product Type By Application By End User By Region |
Regional scope | West and East |
Key companies profiled | Medtronic Malaysia Sdn Bhd, Boston Scientific Medical Device (Malaysia) Sdn. Bhd., BIOTRONIK Medical Devices (Malaysia) SDN BHD, Abbott Malaysia Sdn Bhd, Osypka Medical Asia Pacific Sdn Bhd |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |